Capítulo1: Metabolismo energético

Krupa Das, Sai; B. Roberts, Susan
January 2003
Conocimientos Actuales sobre Nutrición;2003, p3
Book Chapter
The energetic equilibrium is adjusted by particularly sensitive mechanisms which have been identified during the present investigations. The disorders in the energetic equilibrium emerge from the genetic and environmental causes and explain many of the current common health problems in the developed countries and in the developing countries. It is necessary to realize more investigations to put in evidence the exact relative importance of the genetic heredity, the influences at the beginning of the life and the current environmental factors in the prevention, appearance and treatment of the obesity.


Related Articles

  • METABOLIC DISORDERS.  // MPR - Pharmacist's Edition;Spring2013, Vol. 7 Issue 1, p127 

    The article offers information on several drug prescriptions used for the treatment of metabolic disorders particularly obesity. It says that Adipex-P from Teva is used for short-term monotheraphy as adjunct in management of exogenous obesity. It states that Alli from GlaxoSmithKline is used to...

  • Filling the Void. Vash, Peter // JAMA: Journal of the American Medical Association;4/4/2012, Vol. 307 Issue 13, p1381 

    A personal narrative is presented which explores the author's experience of treating Paula's obesity who weighed more than 325 pounds.

  • The Global Epidemic of Obesity: Why Global Approaches Won't Work. Miller, Wayne C. // Healthy Weight Journal;Nov/Dec2001, Vol. 15 Issue 6, p81 

    Editorial. Explores the global epidemic of obesity. Efforts to prevent overweight and obesity; Assumptions underlying obesity treatment paradigms; Efficiency of obesity treatment programs.

  • POHYBOVÁ INTERVENCE JAKOU SOUČÁST LÉČENÍ NADVÁHY A OBEZITY. Poděbradská, R. // Rehabilitation & Physical Medicine / Rehabilitace a Fyzikalni Le;Aug2011, Vol. 18 Issue 2, p50 

    This article contains new aspects of obesity as a disease and an insight into physical activity in treating obesity. Currently, obesity is the most frequent metabolic disease (9) and it is important to search for a common, effective application for its prevention and treatment. Ideally, for a...

  • Obesity in Preschoolers: Behavioral Correlates and Directions for Treatment. Kuhl, Elizabeth S.; Clifford, Lisa M.; Stark, Lori J. // Obesity (19307381);Jan2012, Vol. 20 Issue 1, p3 

    Nearly 14% of American preschoolers (ages 2-5) are obese (BMI = 95th percentile for age and gender), yet this group has received little attention in the obesity intervention literature. This review examines what is known about behavioral correlates of obesity in preschoolers and the...

  • Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Cao, Yihai // Nature Reviews Drug Discovery;Feb2010, Vol. 9 Issue 2, p107 

    Current pharmacotherapeutic options for treating obesity and related metabolic disorders remain limited and ineffective. Emerging evidence shows that modulators of angiogenesis affect the expansion and metabolism of fat mass by regulating the growth and remodelling of the adipose tissue...

  • Inflammatory mechanisms linking obesity and metabolic disease. Saltiel, Alan R.; Olefsky, Jerrold M. // Journal of Clinical Investigation;Jan2017, Vol. 127 Issue 1, p1 

    There are currently over 1.9 billion people who are obese or overweight, leading to a rise in related health complications, including insulin resistance, type 2 diabetes, cardiovascular disease, liver disease, cancer, and neurodegeneration. The finding that obesity and metabolic disorder are...

  • Hypothalamic inflammation in obesity and metabolic disease. Jais, Alexander; Brüning, Jens C. // Journal of Clinical Investigation;Jan2017, Vol. 127 Issue 1, p24 

    Over the last years, hypothalamic inflammation has been linked to the development and progression of obesity and its sequelae. There is accumulating evidence that this inflammation not only impairs energy balance but also contributes to obesity-associated insulin resistance. Elevated activation...

  • Immunologic impact of the intestine in metabolic disease. Winer, Daniel A.; Winer, Shawn; Dranse, Helen J.; Lam, Tony K. T. // Journal of Clinical Investigation;Jan2017, Vol. 127 Issue 1, p33 

    Obesity and diabetes are associated with increased chronic low-grade inflammation and elevated plasma glucose levels. Although inflammation in the fat and liver are established features of obesity-associated insulin resistance, the intestine is emerging as a new site for immunologic changes that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics